Heidelberg Pharma AG

Heidelberg Pharma AGverified

HPHA.DE

Price:

$2.45

Market Cap:

$114.62M

Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It is developing HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for tumors; and HDP-XX for the treatment of solid/hematological tumors. The company is also developing MGTA-ATACs for HSCs, conditioning programs to treat blood cancers/genetic diseases; TAK-ATACs for oncology...[Read more]

Industry

Biotechnology

IPO Date

2006-11-13

Stock Exchange

XETRA

Ticker

HPHA.DE

The Enterprise Value as of December 2025 (TTM) for Heidelberg Pharma AG (HPHA.DE) is 91.88M

According to Heidelberg Pharma AG’s latest financial reports and current stock price. The company's current Enterprise Value is 91.88M. This represents a change of -29.71% compared to the average of 130.72M of the last 4 quarters.

Heidelberg Pharma AG (HPHA.DE) Historical Enterprise Value (quarterly & annually)

How has HPHA.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Heidelberg Pharma AG over the last ten years is 85.37M. The current 91.88M Enterprise Value has changed 10.66% with respect to the historical average. Over the past ten years (40 quarters), HPHA.DE's Enterprise Value was at its highest in in the February 2021 quarter at 255.08M. The Enterprise Value was at its lowest in in the November 2015 quarter at 14.60M.

Quarterly (TTM)
Annual

Average

85.37M

Median

75.84M

Minimum

8.86M

Maximum

172.86M

Heidelberg Pharma AG (HPHA.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Heidelberg Pharma AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 585.18%

Maximum Annual Enterprise Value = 172.86M

Minimum Annual Increase = -82.69%

Minimum Annual Enterprise Value = 8.86M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024104.40M14.73%
202391.00M-38.37%
2022147.64M-14.59%
2021172.86M14.72%
2020150.68M187.24%
201952.46M-13.54%
201860.68M585.18%
20178.86M-82.69%
201651.16M266.38%
201513.96M-2.08%

Heidelberg Pharma AG (HPHA.DE) Average Enterprise Value

How has HPHA.DE Enterprise Value performed in the past?

The current Enterprise Value of Heidelberg Pharma AG (HPHA.DE) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

114.35M

5-year avg

133.32M

10-year avg

85.37M

Heidelberg Pharma AG (HPHA.DE) Enterprise Value vs. Peers

How is HPHA.DE’s Enterprise Value compared to its peers?

Heidelberg Pharma AG’s Enterprise Value is greater than 4basebio PLC (89.98M), less than Zura Bio Limited (139.28M), greater than BRAIN Biotech AG (47.80M), less than Healwell AI Inc (224.39M), less than Mediclin AG (501.48M), less than FamiCord AG (117.00M), less than LIMES Schlosskliniken AG (105.57M), less than MPH Health Care AG (113.70M), greater than Apontis Pharma AG (80.25M), less than H100 Group AB N (566.80M),

CompanyEnterprise ValueMarket cap
89.98M$108.39M
139.28M$234.08M
47.80M$58.33M
224.39M$93.69M
501.48M$171.00M
117.00M$108.95M
105.57M$104.38M
113.70M$104.47M
80.25M$91.63M
566.80M$53.47M

Build a custom stock screener for Heidelberg Pharma AG (HPHA.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heidelberg Pharma AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Heidelberg Pharma AG (HPHA.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Heidelberg Pharma AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Heidelberg Pharma AG's Enterprise Value?

What is the highest Enterprise Value for Heidelberg Pharma AG (HPHA.DE)?

What is the 3-year average Enterprise Value for Heidelberg Pharma AG (HPHA.DE)?

What is the 5-year average Enterprise Value for Heidelberg Pharma AG (HPHA.DE)?

How does the current Enterprise Value for Heidelberg Pharma AG (HPHA.DE) compare to its historical average?